RT published this video item, entitled “Sputnik V COVID jab approved for phase-three trials in India” – below is their description.
The Russian Sputnik V COVID jab has been approved for final-stage trials in India and, if the process goes smoothly, will be used alongside AstraZeneca’s and the country’s own Covaxin jabs.
RT YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
About This Source - RT
The video item below is a piece of English language content from RT (formerly Russia Today). RT is a Russian state-funded broadcaster.
Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.
Symptoms of coronavirus
The main symptoms of coronavirus are:
a persistent new cough (non productive, dry)
a high temperature (e.g. head feels warm to the touch)
shortness of breath (if this is abnormal for the individual, or increased)
Latest News about Covid-19
Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.
India, officially the Republic of India, is a country in South Asia. It is the second-most populous country, the seventh-largest country by land area, and the most populous democracy in the world. New Delhi is the capital.
It has an exceptionally diverse population, with Hindus, Muslims, Christians, Sikhs, Buddhists, Jains and other religions speaking over 21 recognised languages.
Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health. It has been approved for distribution in Russia.
The phase III trial for Gam-COVID-Vac was registered on 28 August 2020, and is a randomised, double-blind, placebo-controlled, multi-centre clinical trial involving 40,000 volunteers. The phase III trial is scheduled to run until May 2021.
On 5 December 2020, Russia began mass vaccinations in Moscow, with 70 clinics inoculating those most at risk from the virus. Health workers and teachers were said to have priority in the first mass immunisation programme. People who had received injections in the last 30 days or had respiratory diseases in the previous two weeks were excluded, as well as those with certain chronic illnesses, and pregnant and breastfeeding women.